Literature DB >> 8187980

Myf5, MyoD, myogenin and MRF4 myogenic derivatives of the embryonic mesenchymal cell line C3H10T1/2 exhibit the same adult muscle phenotype.

F Auradé1, C Pinset, P Chafey, F Gros, D Montarras.   

Abstract

Cells of the embryonic mesenchymal cell line C3H10T1/2 have revealed the potential that the four regulatory factors belonging to the MyoD family have to activate myogenesis. In the present study we have further investigated the myogenic phenotype of C3H10T1/2 cells stably transfected with either Myf5, MyoD, myogenin or MRF4 cDNAs. We have studied the influence of each transfected cDNA on expression of the four endogenous muscle regulatory genes and on the ability of these embryonic myogenic derivatives to express adult muscle genes. No trace of endogenous transcripts distinct from the exogenous one was found in any of the four converted populations at the myoblast stage. This indicates that cross-activation within the MyoD family does not occur at the myoblast stage in these cells. Similarly, evidence was obtained that auto- or cross-activation of the Myf5 gene occurs neither at the myoblast stage nor at the myotube stage and that no autoactivation of the MRF4 gene occurs. Our results together with previous observations indicate that in C3H10T1/2 myogenic derivatives: (1) Autoactivation at the myoblast stage is restricted to MyoD (2) Expression from each cDNA alone is sufficient to establish and maintain the myoblast phenotype (3) The endogenous Myf5 gene is not mobilized. We have also observed that endogenous transcripts for MyoD and myogenin begin to accumulate at the onset of differentiation in the four myogenic derivatives, whereas accumulation of endogenous MRF4 transcripts starts after myotubes have formed and occurs at a much lower level (100- to 500-fold lower) than in differentiated cultures of myosatellite cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8187980     DOI: 10.1046/j.1432-0436.1994.5530185.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  22 in total

1.  Constitutive instability of muscle regulatory factor Myf5 is distinct from its mitosis-specific disappearance, which requires a D-box-like motif overlapping the basic domain.

Authors:  C Lindon; O Albagli; P Domeyne; D Montarras; C Pinset
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon.

Authors:  C j Liu; H Wang; Z Zhao; S Yu; Y B Lu; J Meyer; G Chatterjee; S Deschamps; B A Roe; P Lengyel
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Differences between MyoD DNA binding and activation site requirements revealed by functional random sequence selection.

Authors:  J Huang; T K Blackwell; L Kedes; H Weintraub
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

4.  Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.

Authors:  P Dhordain; O Albagli; R J Lin; S Ansieau; S Quief; A Leutz; J P Kerckaert; R M Evans; D Leprince
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity by p202.

Authors:  B Datta; W Min; S Burma; P Lengyel
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

6.  Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation.

Authors:  Shu-Ching Huang; Anyu Zhou; Dan T Nguyen; Henry S Zhang; Edward J Benz
Journal:  J Biol Chem       Date:  2016-10-25       Impact factor: 5.157

7.  Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation.

Authors:  Chang-Hao Cui; Taro Uyama; Kenji Miyado; Masanori Terai; Satoru Kyo; Tohru Kiyono; Akihiro Umezawa
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

Review 8.  Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.

Authors:  N J Sebire; M Malone
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

9.  Beta-catenin interacts with MyoD and regulates its transcription activity.

Authors:  Chang-Hoon Kim; Hannah Neiswender; Eun Joo Baik; Wen C Xiong; Lin Mei
Journal:  Mol Cell Biol       Date:  2008-03-03       Impact factor: 4.272

10.  SMYD1, the myogenic activator, is a direct target of serum response factor and myogenin.

Authors:  Dali Li; Zhiyv Niu; Weishi Yu; Yu Qian; Qian Wang; Qiang Li; Zhengfang Yi; Jian Luo; Xiushan Wu; Yuequn Wang; Robert J Schwartz; Mingyao Liu
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.